Tvardi Therapeutics, Inc. (TVRD)
2.80
-0.05
(-1.75%)
USD |
NASDAQ |
Jun 09, 16:00
2.80
0.00 (0.00%)
After-Hours: 20:00
Tvardi Therapeutics SG&A Expense (Quarterly) : 2.14M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Nektar Therapeutics | 13.44M |
| Assertio Holdings, Inc. | 11.14M |
| Eli Lilly & Co. | 2.934B |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |